Proteomic analysis of rat tibialis anterior muscles at different stages of experimental autoimmune myasthenia gravis

被引:5
|
作者
Gomez, Alejandro M. [1 ]
Vanheel, Annelies [2 ,3 ]
Losen, Mario [1 ]
Molenaar, Peter C. [1 ]
De Baets, Marc H. [1 ,2 ,3 ]
Noben, Jean-Paul [2 ,3 ]
Hellings, Niels [2 ,3 ]
Martinez-Martinez, Pilar [1 ]
机构
[1] Maastricht Univ, Sch Mental Hlth & Neurosci, Div Neurosci, NL-6200 MD Maastricht, Netherlands
[2] Hasselt Univ, Biomed Res Inst, B-3500 Hasselt, Belgium
[3] Transnatl Univ Limburg, Sch Life Sci, B-3500 Hasselt, Belgium
关键词
Myasthenia gravis; Muscle proteomics; 2D-DIGE; Autoimmunity; CARBONIC-ANHYDRASE-III; MEMBRANE-PROTEINS; SKELETAL-MUSCLE; ALPHA; BETA; QUANTIFICATION; DENERVATION; EXPRESSION; ANTIBODIES; DISEASES;
D O I
10.1016/j.jneuroim.2013.05.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myasthenia gravis (MG) is an autoimmune disease in which autoantibodies, most commonly directed against the acetylcholine receptor (AChR), impair neuromuscular transmission and cause muscle weakness. In this study, we utilized two-dimensional difference in-gel electrophoresis (2D-DIGE) to analyze the muscles proteomic profile at different stages of experimental autoimmune myasthenia gravis (EAMG). We identified twenty-two differentially expressed proteins, mainly related to metabolic and stress-response pathways. Interestingly, these identified proteins have also been associated with other contraction-impairing muscle pathologies (e.g. inclusion body myositis), suggesting a similar response of the muscle to such conditions. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:141 / 145
页数:5
相关论文
共 50 条
  • [21] EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS AND MYASTHENIA-GRAVIS - COMPARISON OF THE IMMUNOLOGICAL RESULTS OBTAINED
    GEFFARD, M
    SOUAN, ML
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 505 : 712 - 714
  • [22] CYTOKINE DIFFERENTIATION IN RELATION TO HUMAN MYASTHENIA-GRAVIS AND EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS
    LINK, H
    WANG, ZY
    OLSSON, T
    NEUROLOGY, 1994, 44 (04) : A189 - A189
  • [23] Acetylcholine receptor-specific immunosuppressive therapy of experimental autoimmune myasthenia gravis and myasthenia gravis
    Luo, Jie
    Lindstrom, Jon
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1413 (01) : 76 - 81
  • [24] THE THYMUS IN MYASTHENIA-GRAVIS - CHANGES TYPICAL FOR THE HUMAN-DISEASE ARE ABSENT IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS OF THE LEWIS RAT
    MEINL, E
    KLINKERT, WEF
    WEKERLE, H
    AMERICAN JOURNAL OF PATHOLOGY, 1991, 139 (05): : 995 - 1008
  • [25] Bortezomib as a novel treatment for experimental autoimmune myasthenia gravis
    Alejandro, Gomez
    Kathleen, Vrolix
    Marko, Phernambucq
    Pilar, Martinez-Martinez
    De Baets, Marc H.
    Mario, Losen
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 88 - 89
  • [26] STEROID TREATMENT FOR EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS
    BARONE, DA
    LAMBERT, DH
    POSER, CM
    ARCHIVES OF NEUROLOGY, 1980, 37 (10) : 663 - 666
  • [27] ICOS is essential for the development of experimental autoimmune myasthenia gravis
    Scott, BG
    Yang, HA
    Tüzün, E
    Dong, C
    Flavell, RA
    Christadoss, P
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 153 (1-2) : 16 - 25
  • [28] CYTOPHILIC ANTIBODIES IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS
    MARTINEZ, RD
    TARRABHAZDAI, R
    AHARONOV, A
    FUCHS, S
    JOURNAL OF IMMUNOLOGY, 1977, 118 (01): : 17 - 20
  • [29] Valproic acid ameliorates experimental autoimmune myasthenia gravis
    Kanai, T.
    Uzawa, A.
    Kawaguchi, N.
    Himuro, K.
    Oda, F.
    Ozawa, Y.
    Kuwabara, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 471 - 471